The #HTA process is one that many countries will need to go through in order to access new treatments. It is part of the decision making process that determines which new therapies are reimbursed in a country. 3/

Martin is a patient member of the visually impaired community in Norway.
He is heavily involved in the #HTA process that hopes to bring the new gene therapy Luxturna to Norway. He will share with us his experience so far. 2/

Health Technology Assessment #HTA from a patient's perspective - RI Webinar July 22nd 4pm CET

The next topic in our webinar series is "HTA from a patient's perspective" with Martin Smedstad, addressing a major step in the access to new medicines process 1/